PRLD
NASDAQ
US
Prelude Therapeutics Incorporated - Common Stock
$3.46
▲ +$0.01
(+0.29%)
Vol 106K
3
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$164.2M
ROE
-51.0%
D/E
0.00
Beta
0.98
52W
$1–$4
Wall Street Consensus
9 analysts · Apr 20263
Strong Buy
5
Buy
1
Hold
0
Sell
0
Strong Sell
88.9%
Buy Rating
Price Chart
Similar Stocks
GALT
Galectin Therapeutics Inc
$268.2M
ACHV
Achieve Life Sciences Inc
$264.6M
SGMT
Sagimet Biosciences Inc
$183.5M
CNTN
Canton Strategic Holdings Inc
CNTB
Connect Biopharma Holdings Ltd
$157.6M
ARTV
Artiva Biotherapeutics Inc
$105.3M
RNAC
Cartesian Therapeutics Inc
$187.5M
WHWK
Whitehawk Therapeutics Inc
$114.1M
NKTX
Nkarta Inc
$131.4M
ABOS
Acumen Pharmaceuticals Inc
$127.8M
Earnings
Beat rate: 75.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $-0.03 | $-0.20 | $-0.17 |
| Sep 2025 | $-0.37 | $-0.26 | +$0.11 |
| Jun 2025 | $-0.45 | $-0.41 | +$0.04 |
| Mar 2025 | $-0.48 | $-0.42 | +$0.06 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | -74.7% | -74.7% | -74.7% | -51.0% | -51.0% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 3.68 | 3.68 | 3.68 | 3.68 | 3.21 | 3.21 |
Key Ratios
ROA (TTM)
-35.9%
P/B
0.5
EPS (TTM)
$-0.64
CF/Share
$-2.12
52W High
$4.22
52W Low
$0.61
$0.61
52-Week Range
$4.22
How does PRLD compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
PRLD valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼
0%
below
peers
(12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
0.5
▼
78%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
PRLD profitability vs Biotechnology peers
ROE
-51.0%
▲
24%
above
peers
(-67.3%)
vs Peers
vs Industry
Below avg
Net margin
—
▼
0%
below
peers
(-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-35.9%
▲
23%
above
peers
(-46.7%)
vs Peers
vs Industry
Below avg
PRLD financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
3.2
▼
28%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
1.0
▲
1%
above
peers
(1.0)
vs Peers
vs Industry
Less volatile
PRLD fundamentals radar
PRLD
Peer median
Industry
PRLD profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
PRLD vs peers: key metrics
Latest News
No related news yet